pyruvaldehyde has been researched along with masoprocol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatipoglu, OF; Ikegami, R; Mori, S; Nishibori, M; Nishinaka, T; Sada, M; Suwaki, Y; Takahashi, H; Toyomura, T; Wake, H; Watanabe, M | 1 |
1 other study(ies) available for pyruvaldehyde and masoprocol
| Article | Year |
|---|---|
Nordihydroguaiaretic acid inhibits glyoxalase I, and causes the accumulation of methylglyoxal followed by cell-growth inhibition.
Topics: Cell Line; Cell Proliferation; Humans; Lactoylglutathione Lyase; Magnesium Oxide; Masoprocol; Pyruvaldehyde | 2022 |